UPC extends Dexcom's deadline to respond to Abbott's counterclaim for patent revocation
MLex Summary: Dexcom's deadline for filing a rejoinder to Abbott's counterclaim for revocation and a reply to a conditional application to amend has been extended to Dec. 11 by the Düsseldorf...To view the full article, register now.
Already a subscriber? Click here to view full article